Scarica l'app Stockscreener
535.00
1.17%
-6.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ISRG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$541.34
Aprire:
$542
Volume 24 ore:
3.05M
Relative Volume:
1.53
Capitalizzazione di mercato:
$189.66B
Reddito:
$9.61B
Utile/perdita netta:
$2.77B
Rapporto P/E:
70.81
EPS:
7.555
Flusso di cassa netto:
$2.27B
1 W Prestazione:
-8.74%
1M Prestazione:
-3.53%
6M Prestazione:
+4.36%
1 anno Prestazione:
-8.40%
Intervallo 1D:
$532.63
$543.00
Intervallo di 1 settimana:
$528.00
$582.19
Portata 52W:
$425.00
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Nome
Intuitive Surgical Inc
Settore
Industria
Telefono
(408) 523-2100
Indirizzo
1020 KIFER ROAD, SUNNYVALE
Confronta ISRG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-07-23 | Downgrade | Erste Group | Buy → Hold |
| 2025-06-09 | Downgrade | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Reiterato | Citigroup | Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-11-17 | Iniziato | HSBC Securities | Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-19 | Reiterato | BTIG Research | Buy |
| 2023-04-19 | Reiterato | BofA Securities | Buy |
| 2023-04-19 | Reiterato | Citigroup | Buy |
| 2023-04-19 | Reiterato | Evercore ISI | In-line |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-19 | Reiterato | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-04-19 | Reiterato | Raymond James | Outperform |
| 2023-04-19 | Reiterato | Stifel | Buy |
| 2023-04-19 | Reiterato | Truist | Buy |
| 2023-04-19 | Reiterato | Wells Fargo | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-23 | Iniziato | William Blair | Outperform |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Neutral |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Downgrade | Redburn | Buy → Neutral |
| 2022-01-21 | Reiterato | BTIG Research | Buy |
| 2022-01-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-21 | Reiterato | Deutsche Bank | Hold |
| 2022-01-21 | Reiterato | Evercore ISI | In-line |
| 2022-01-21 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Reiterato | Piper Sandler | Neutral |
| 2022-01-21 | Reiterato | Raymond James | Outperform |
| 2022-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2022-01-21 | Reiterato | Stifel | Buy |
| 2022-01-21 | Reiterato | UBS | Neutral |
| 2022-01-21 | Reiterato | Wells Fargo | Overweight |
| 2022-01-10 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2021-07-21 | Reiterato | BofA Securities | Neutral |
| 2021-07-21 | Reiterato | Citigroup | Buy |
| 2021-07-21 | Reiterato | JP Morgan | Overweight |
| 2021-07-21 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Reiterato | Piper Sandler | Neutral |
| 2021-07-21 | Reiterato | SVB Leerink | Mkt Perform |
| 2021-07-21 | Reiterato | Stifel | Buy |
| 2021-07-21 | Reiterato | UBS | Neutral |
| 2021-07-21 | Reiterato | Wells Fargo | Overweight |
| 2021-07-14 | Reiterato | Goldman | Buy |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Iniziato | Citigroup | Buy |
| 2020-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Iniziato | Argus | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-07-20 | Reiterato | Bernstein | Outperform |
| 2020-04-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Downgrade | CFRA | Hold → Sell |
| 2020-04-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Downgrade | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Reiterato | Wells Fargo | Outperform |
| 2019-11-21 | Iniziato | Oppenheimer | Perform |
| 2019-07-19 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-22 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-02 | Iniziato | Deutsche Bank | Buy |
| 2018-10-31 | Reiterato | Piper Jaffray | Overweight |
| 2018-10-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
Mostra tutto
Intuitive Surgical Inc Borsa (ISRG) Ultime notizie
ISRG (Intuitive Surgical, NASDAQ) down 2.46% intraday 16 Jan 2026: procedure growth guide vs AI growth outlook - Meyka
Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings - TechStock²
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results - TradingView — Track All Markets
Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder (NASDAQ:ISRG) - Seeking Alpha
Intuitive says general surgery, acute care fuel US robot momentum - MedTech Dive
Intuitive Surgical Advances Phase 3 Imaging Drug to Cut Ureter Injuries in Robotic Colorectal Surgery - TipRanks
Dedicated Surgeon Dr. Sharona Ross Recently Featured on Close Up Radio - The National Law Review
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet - Finviz
Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
Bernstein reiterates Outperform rating on Intuitive Surgical stock at $740 By Investing.com - Investing.com UK
Wilmington Savings Fund Society FSB Has $246.16 Million Position in Intuitive Surgical, Inc. $ISRG - MarketBeat
Intuitive Surgical, Inc. $ISRG Holdings Boosted by PGGM Investments - MarketBeat
The Zacks Analyst Blog Highlights American Express, Intuitive Surgical, Booking Holdings, Daily Journal and Star Group - Nasdaq
Nordea Investment Management AB Has $21.27 Million Position in Intuitive Surgical, Inc. $ISRG - MarketBeat
Davis Rea LTD. Buys New Shares in Intuitive Surgical, Inc. $ISRG - MarketBeat
Campbell & CO Investment Adviser LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG - MarketBeat
Grande Ronde Hospital Foundation Raises Funds for da Vinci 5 Surgical System - La Grande Observer
Pay Less, Gain More: PODD Tops Intuitive Surgical Stock - Trefis
Activity Recap: Can TIMB disrupt its industryTrend Reversal & Weekly High Return Stock Opportunities - baoquankhu1.vn
Earnings Preview: Intuitive Surgical (ISRG) looks poised for a strong Q4 - AlphaStreet
The Truth About Intuitive Surgical Stock: Is This Robot Surgeon Still Worth Your Money? - AD HOC NEWS
Top Stock Reports for American Express, Intuitive Surgical & Booking - Yahoo Finance
Intuitive Surgical (ISRG) Is Down 7.7% After Tempered 2026 Procedure Outlook Despite Strong 2025 GuidanceHas The Bull Case Changed? - simplywall.st
Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG - TechStock²
Intuitive Surgical’s IS-001 Phase 3 Update: What Investors Should Know About This Imaging-Driven Safety Play - TipRanks
Intuitive Surgical stock beats Q4 expectations as UBS maintains Neutral rating - Investing.com
Intuitive Surgical expands platforms despite market headwind - Medical Device Network
JPM26: Intuitive’s stock falls despite positive FY25 financials - Medical Device Network
Intuitive Surgical Sets Softer 2026 Outlook - GuruFocus
California-based Intuitive expects 19% revenue increase in Q4 2025 - Medical Buyer
TD Private Client Wealth LLC Sells 2,412 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
Intuitive Surgical (NASDAQ:ISRG) Shares Acquired Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Intuitive Surgical (ISRG) stock drops after 2026 da Vinci outlook flags slower growth - TechStock²
Intuitive says daVinci systems ‘exceeded expectations,’ it wants more - MassDevice
Why This Robotics Giant Crumbled Despite Its Quarterly Beat - Investor's Business Daily
Intuitive Surgical slips, Airbnb hires Meta's former GenAI chief - Yahoo Finance
Intuitive Surgical: DV5 Adoption, Innovation Pipeline, and Robust Growth Outlook Support Premium-Valued Buy Rating - TipRanks
Intuitive Surgical (ISRG) Shares Dip on 2026 Growth Forecast - GuruFocus
ISRG: 2025 saw record growth and innovation, with 2026 set for global expansion and digital advances - TradingView — Track All Markets
Intuitive Surgical Falls as Rivalry Slows Down Flagship Robot - Bloomberg.com
Intuitive Surgical (NASDAQ:ISRG) Shares Gap DownWhat's Next? - MarketBeat
Why Intuitive Surgical Stock Is Falling Today - GuruFocus
Intuitive Surgical Updates Q4 Revenue Guidance Amid Growth Concerns - GuruFocus
Why Intuitive Surgical Stock Dropped Today - Yahoo Finance
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 - Yahoo Finance
Intuitive Reports Strong Preliminary Q4 And Full-Year 2025 Growth Ahead - Nasdaq
Why Intuitive Surgical Stock Dropped Today - The Motley Fool
Intuitive Surgical (ISRG) Shares Dip Despite Strong Revenue Grow - GuruFocus
Intuitive Surgical, Inc. Provides Earnings Guidance for the Fourth Quarter and Year Ended December 31, 2025 - marketscreener.com
Intuitive reports 19% revenue growth in Q4 2025, procedure surge By Investing.com - Investing.com India
ISRG: Strong Growth in Surgical Procedures for Q4 2025 - GuruFocus
Intuitive Surgical Inc Azioni (ISRG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.60%
3.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):